Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · August 27, 2023

Efficacy of Longitudinal Monitoring of Plasma ctDNA in Patients With Curative Resected Stage I–IIIA EGFR-Mutant NSCLC

Journal of Thoracic Oncology


Additional Info

Journal of Thoracic Oncology
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer
J Thorac Oncol 2023 Jun 10;[EPub Ahead of Print], HA Jung, BM Ku, YJ Kim, S Park, JM Sun, SH Lee, JS Ahn, JH Cho, HK Kim, YS Choi, YL Choi, SH Shin, BH Jeong, SW Um, H Kim, K Kim, MJ Ahn, J Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading